Connor, Clark & Lunn Investment Management (CC&L)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$844K Buy
3,554
+2,058
+138% +$428K ﹤0.01% 1239
2026
Q1
$316K Sell
1,496
-62,332
-98% -$13.4M ﹤0.01% 1412
2025
Q4
$13.1M Buy
+63,828
New +$12M 0.03% 390
2025
Q3
Sell
-1,318
Closed -$221K 1513
2025
Q2
$221K Buy
+1,318
New +$196K ﹤0.01% 1404
2024
Q3
Sell
-10,241
Closed -$1.01M 1454
2024
Q2
$1.01M Sell
10,241
-54,365
-84% -$5.54M ﹤0.01% 845
2024
Q1
$7.23M Sell
64,606
-114,849
-64% -$12.4M 0.03% 360
2023
Q4
$18.1M Buy
179,455
+133,856
+294% +$13.3M 0.08% 194
2023
Q3
$3.96M Buy
45,599
+39,704
+674% +$3.59M 0.02% 448
2023
Q2
$557K Buy
+5,895
New +$498K ﹤0.01% 962
2023
Q1
Sell
-82,076
Closed -$6.31M 1260
2022
Q4
$6.31M Buy
+82,076
New +$6.24M 0.04% 307
2022
Q2
Sell
-173,572
Closed -$9.84M 1054
2022
Q1
$9.84M Sell
173,572
-256,806
-60% -$13.8M 0.05% 226
2021
Q4
$22.2M Buy
430,378
+18,902
+5% +$927K 0.11% 155
2021
Q3
$20.4M Buy
411,476
+371,783
+937% +$20.2M 0.11% 156
2021
Q2
$2.27M Buy
39,693
+1,602
+4% +$93.6K 0.01% 511
2021
Q1
$2.31M Sell
38,091
-36,357
-49% -$2.01M 0.01% 526
2020
Q4
$3.99M Buy
74,448
+17,569
+31% +$912K 0.02% 386
2020
Q3
$2.67M Sell
56,879
-15,523
-21% -$797K 0.02% 423
2020
Q2
$3.78M Sell
72,402
-17,548
-20% -$905K 0.03% 345
2020
Q1
$4.31M Buy
+89,950
New +$4.67M 0.04% 276
2016
Q1
Sell
-3,100
Closed -$277K 834
2015
Q4
$277K Buy
+3,100
New +$263K ﹤0.01% 645
2015
Q1
Sell
-17,288
Closed -$1.4M 571
2014
Q4
$1.4M Sell
17,288
-19,300
-53% -$1.52M 0.01% 265
2014
Q3
$2.74M Sell
36,588
-3,200
-8% -$233K 0.02% 186
2014
Q2
$2.91M Buy
39,788
+7,000
+21% +$477K 0.02% 206
2014
Q1
$2.53M Buy
32,788
+25,000
+321% +$1.74M 0.02% 246
2013
Q4
$553K Buy
+7,788
New +$476K ﹤0.01% 470

Other funds holding CAH

Connor, Clark & Lunn Investment Management (CC&L)'s CAH Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Cardinal Health (CAH) stake by 138% in Q2 2026, buying an estimated $428K and bringing the position to 3,554 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CAH in Q4 2013 and has held it in 25 quarters since. The position peaked at $22.2M in Q4 2021. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 3,554 shares of Cardinal Health worth $844K as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 2,058 Cardinal Health shares in Q2 2026, an estimated $428K.
  • Cardinal Health made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1239 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Cardinal Health in Q4 2013 and has held it in 25 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Cardinal Health position peaked at $22.2M in Q4 2021.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.